Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet. 2016;388(10060):2654–2664.
   PubMed Web of Science ®Google Scholar
• Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
   PubMed Web of Science ®Google Scholar
• Kamran SC, Hong TS, Wo JY. Advances in the Management of Gastric and Gastroesophageal Cancers. Curr Oncol Rep. 2016;18(2):13.
   PubMed Web of Science ®Google Scholar
• Chivu-Economescu M, Matei L, Necula LG, et al. New therapeutic options opened by the molecular classification of gastric cancer. World J Gastroenterol. 2018;24(18):1942–1961.
   PubMed Web of Science ®Google Scholar
• Lv C, Shi C, Li L, et al. Chinese herbal medicines in the prevention and treatment of chemotherapy-induced nausea and vomiting. Curr Opin Support Palliat Care. 2018;12(2):174–180.
   PubMed Web of Science ®Google Scholar
• Tao WW, Jiang H, Tao XM, et al. Effects of Acupuncture, Tuina, Tai Chi, Qigong, and Traditional Chinese Medicine Five-Element Music Therapy on Symptom Management and Quality of Life for Cancer Patients: a Meta-Analysis. J Pain Symptom Manage. 2016;51(4):728–747.
   PubMed Web of Science ®Google Scholar
• Liao YH, Li CI, Lin CC, et al. Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients. J Cancer Res Clin Oncol. 2017;143(12):2425–2435.
   PubMed Web of Science ®Google Scholar
• Yuan K, Li X, Lu Q, et al. Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review. Front Pharmacol. 2019;10:1469.
   PubMed Web of Science ®Google Scholar
• Qiu D, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D. 2003;4(1):1–18.
   PubMedGoogle Scholar
• Hu H, Zhu S, Tong Y, et al. Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro. Anticancer Drugs. 2020;31(5):483–491.
   PubMed Web of Science ®Google Scholar
• Hinshaw DC, Shevde LA. The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Res. 2019;79(18):4557–4566.
   PubMed Web of Science ®Google Scholar
• Noel P, Von Hoff DD, Saluja AK, et al. Its Derivatives as Cancer Therapies. Trends Pharmacol Sci. 2019;40(5):327–341.
   PubMed Web of Science ®Google Scholar
• Hou ZY, Tong XP, Peng YB, et al. Broad targeting of triptolide to resistance and sensitization for cancer therapy. Biomed Pharmacother. 2018;104:771–780.
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martinez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4(1):2612.
   PubMed Web of Science ®Google Scholar
• Wang T, Chen B, Meng T, et al. Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma. Bioengineered. 2021;12(1):1555–1575.
   PubMed Web of Science ®Google Scholar
• Islam T, Rahman MR, Aydin B, et al. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19. Eur J Pharmacol. 2020;887:173594.
   PubMed Web of Science ®Google Scholar
• Yan H, Zheng G, Qu J, et al. Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis. J Cell Physiol. 2019;234(12):23785–23797.
   PubMed Web of Science ®Google Scholar
• Zhang YF, Huang Y, Ni YH, et al. Systematic elucidation of the mechanism of geraniol via network pharmacology. Drug Des Devel Ther. 2019;13:1069–1075.
   PubMed Web of Science ®Google Scholar
• von Mering C, Huynen M, Jaeggi D, et al. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31(1):258–261.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6(1):13.
   PubMed Web of Science ®Google Scholar
• Bi KW, Wei XG, Qin XX, et al. BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: a Study Based on TCGA Data Mining. Front Oncol. 2020;10:424.
   PubMed Web of Science ®Google Scholar
• Guo R, Li X, Chen X, et al. An ultrasonic-extracted arabinoglucan from Tamarindus indica L. pulp: a study on molecular and structural characterizations. Int J Biol Macromol. 2020;164:3687–3697.
   PubMed Web of Science ®Google Scholar
• Wu B, Chien EY, Mol CD, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010;330(6007):1066–1071.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Cao L, Guan L, et al. Immunotherapy for gastric cancer: dilemmas and prospect. Brief Funct Genomics. 2019;18(2):107–112.
   PubMed Web of Science ®Google Scholar
• Schlosser HA, Drebber U, Kloth M, et al. Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma. Oncoimmunology. 2016;5(5):e1100789.
   PubMed Web of Science ®Google Scholar
• Li Z, Lai Y, Sun L, et al. PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer. Hum Pathol. 2016;55:182–189.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu X, Chen Y. Stromal-Immune Score-Based Gene Signature: a Prognosis Stratification Tool in Gastric Cancer. Front Oncol. 2019;9:1212.
   PubMed Web of Science ®Google Scholar
• Jia D, Li S, Li D, et al. TCGA database for genes of prognostic value in glioblastoma microenvironment. Aging (Albany NY). 2018;10(4):592–605.
   PubMedGoogle Scholar
• Mao M, Yu Q, Huang R, et al. Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironment. Cancer Med. 2020;9(14):4980–4990.
   PubMed Web of Science ®Google Scholar
• Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14(6):e218–228.
   PubMed Web of Science ®Google Scholar
• Saxena R, Wang Y, Mier JW. CXCR4 inhibition modulates the tumor microenvironment and retards the growth of B16-OVA melanoma and Renca tumors. Melanoma Res. 2020;30(1):14–25.
   PubMed Web of Science ®Google Scholar
• Izumi D, Ishimoto T, Miyake K, et al. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin beta1 clustering and invasiveness in gastric cancer. Int J Cancer. 2016;138(5):1207–1219.
   PubMed Web of Science ®Google Scholar
• Perrot-Applanat M, Vacher S, Pimpie C, et al. Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer. Oncol Lett. 2019;18(1):674–686.
   PubMed Web of Science ®Google Scholar
• Yang J, Kumar A, Vilgelm AE, et al. Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Cancer Immunol Res. 2018;6(10):1186–1198.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang H, Wang H, et al. Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4. Bioengineered. 2021;12(1):496–506.
   PubMed Web of Science ®Google Scholar
• Zou D, Wang Y, Wang M, et al. Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas. Bioengineered. 2021;12(1):496–506.
   PubMed Web of Science ®Google Scholar
• Zhang J, Pang Y, Xie T, et al. CXCR4 antagonism in combination with IDO1 inhibition weakens immune suppression and inhibits tumor growth in mouse breast cancer bone metastases. Onco Targets Ther. 2019;12:4985–4992.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Li B, Liang Y, et al. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment. FASEB J. 2019;33(5):6596–6608.
   PubMed Web of Science ®Google Scholar
• Masuda T, Nakashima Y, Ando K, et al. Nuclear expression of chemokine receptor CXCR4 indicates poorer prognosis in gastric cancer. Anticancer Res. 2014;34(11):6397–6403.
   PubMed Web of Science ®Google Scholar
• Xiang Z, Zhou ZJ, Xia GK, et al. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis. Oncogene. 2017;36(36):5122–5133.
   PubMed Web of Science ®Google Scholar
• Mortezaee K. CXCL12/CXCR4 axis in the microenvironment of solid tumors: a critical mediator of metastasis. Life Sci. 2020;249:117534.
   PubMed Web of Science ®Google Scholar
• Liu B, Zhang H, Li J, et al. Triptolide downregulates Treg cells and the level of IL-10, TGF-beta, and VEGF in melanoma-bearing mice. Planta Med. 2013;79(15):1401–1407.
   PubMed Web of Science ®Google Scholar
• Wei J, Yan Y, Chen X, et al. The Roles of Plant-Derived Triptolide on Non-Small Cell Lung Cancer. Oncol Res. 2019;27(7):849–858.
   PubMed Web of Science ®Google Scholar
• Isharwal S, Modi S, Arora N, et al. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants. Prostate. 2017;77(6):584–596.
   PubMed Web of Science ®Google Scholar
• Oliveira A, Beyer G, Chugh R, et al. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F. Lab Invest. 2015;95(6):648–659.
   PubMed Web of Science ®Google Scholar
• Wang H, Ma D, Wang C, et al. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-kappaB Signaling. Med Sci Monit. 2016;1:1827–1836.
   Google Scholar
• Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559–572.
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors. Int J Oncol. 2010;36(2):415–420.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang H, Cai J, et al. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-kappaB signaling. Exp Cell Res. 2018;365(1):12–23.
   PubMed Web of Science ®Google Scholar
• Ma YK, Chen YB, Li P. Quercetin inhibits NTHi-triggered CXCR4 activation through suppressing IKKalpha/NF-kappaB and MAPK signaling pathways in otitis media. Int J Mol Med. 2018;42(1):248–258.
   PubMed Web of Science ®Google Scholar
• Guo Z, Chen W, Dai G, et al. Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4. Int J Mol Med. 2020;45(1):141–150.
   PubMed Web of Science ®Google Scholar
• Oh YS, Kim HY, Song IC, et al. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1alpha. Oncol Rep. 2012;28(6):2239–2246.
   PubMed Web of Science ®Google Scholar
• Liaw K, Sharma R, Sharma A, et al. Appiani La Rosa S, Kannan RM. Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma. J Control Release. 2021;329:434–444.
   PubMed Web of Science ®Google Scholar
• Chugh R, Sangwan V, Patil SP, et al. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer. Sci Transl Med. 2012;4(156):156ra139–156ra139. 156ra139.
   PubMedGoogle Scholar